Prevalence of Cannabis Use and Cannabis Route of Administration among Massachusetts Adults in Buprenorphine Treatment for Opioid Use Disorder.
Saved in:
| Title: | Prevalence of Cannabis Use and Cannabis Route of Administration among Massachusetts Adults in Buprenorphine Treatment for Opioid Use Disorder. |
|---|---|
| Authors: | Streck, Joanna M. (AUTHOR), Regan, Susan (AUTHOR), Bearnot, Benjamin (AUTHOR), Gupta, Priya S. (AUTHOR), Kalkhoran, Sara (AUTHOR), Kalagher, Kelly M. (AUTHOR), Wakeman, Sarah (AUTHOR), Rigotti, Nancy A. (AUTHOR) |
| Source: | Substance Use & Misuse. 2022, Vol. 57 Issue 7, p1104-1110. 7p. 1 Chart, 1 Graph. |
| Subjects: | Cannabis (Genus), Substance abuse, Electronic cigarettes, Confidence intervals, Buprenorphine, Cross-sectional method, Multiple regression analysis, Community health services, Race, Disease prevalence, Medical marijuana, Descriptive statistics, Smoking, White people, Therapeutics, Adults |
| Geographic Terms: | Massachusetts |
| Abstract: | Recent prevalence estimates of cannabis use among individuals receiving medication treatment for OUD (MOUD) are lacking, and no study has characterized cannabis route of administration (cROA) in this population. These knowledge gaps are relevant because cannabis' effects and health outcomes vary by cROA and the availability and perceptions of cROA (e.g., vaping devices) are changing. The Vaping In Buprenorphine-treated patients Evaluation (VIBE) cross-sectional survey assessed the prevalence and correlates of cannabis use and cROA among adults receiving buprenorphine MOUD from 02/20 to 07/20 at five community health centers in Massachusetts, a state with legal recreational and medical cannabis use. Among the 92/222 (41%) respondents reporting past 30-day cannabis use, smoking was the most common cROA (75%), followed by vaping (38%), and eating (26%). Smoking was more often used as a single cROA vs. in combination others (p = 0.01), whereas vaping, eating, and dabbing were more often used in combination with another cROA (all p < 0.05). Of the 39% of participants reporting multiple cROA, smoking and vaping (61%), and smoking and eating (50%), were the most prevalent combinations. Nonwhite race (vs. white) and current cigarette smoking (vs. no nicotine use) were associated with past 30-day cannabis use in multiple logistic regression. Prevalence of past 30-day cannabis use among individuals receiving buprenorphine MOUD in Massachusetts in 2020 was nearly double the prevalence of cannabis use in Massachusetts' adult general population in 2019 (21%). Our data are consistent with state and national data showing smoking as the most common cROA. [ABSTRACT FROM AUTHOR] |
| Copyright of Substance Use & Misuse is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
